Lung Cancer Screening Test
LungScreen is a unique easy to use at-home sample collection kit that screens for antibodies that can be linked to an increased risk of developing lung cancer.
Do you have a smoking history of 1 pack daily for 20 years? Or, any smoking history with a close family history of lung cancer (parent, sibling, child)
Why Lung Screening is necessary?
Klarity’s cancer screening services are clinically governed by age restrictions, if you are not within the age range for a service you will not be able to sign up to that service. This is because clinical research does not support the benefits of screening people outside our specified age eligibilities. Regardless of age, if you have symptoms then you should always seek medical advice from your GP.
Why should I get checked for lung cancer?
If you smoke or have smoked heavily-more than 20 per day. And or have a close family history of lung cancer (parent, sibling, child), then LungScreen provides you with early detection often before symptoms arise. Smoking, directly or indirectly, is connected with 80% of all lung cancers. Currently there is no NHS screening programme for lung cancer in the UK. The survival of people with early stage lung cancer is much better than those diagnosed at a later stage.
The lung cancer screening test?
You will receive a sterile collection kit, which is sent to your home, containing easy to follow step-by-step instructions. Return your sample to the laboratory and you can expect your results within two weeks of the laboratory receiving your sample. Your results will be available in your Klarity member’s page. One of our clinical team will contact you to discuss your results and assist with any questions you may have.
How does it work?
CervicalScreen is a reliable, easy to use at-home cervical cancer screening kit that detects the Human papillomavirus (HPV), the virus that causes cervical cancer. For 90% of women, using CervicalScreen means you may never need to have a smear test again. CervicalScreen tests for the 13 high-risk sub-types of HPV, identifying women potentially at a high risk of cervical cancer. The NHS does not currently report on HPV sub-types.